BioCentury
ARTICLE | Company News

DRC approves Merck vaccine for use in Ebola outbreak

May 14, 2018 10:13 PM UTC

The Democratic Republic of the Congo approved a protocol to use Ebola vaccine rVSV-ZEBOV (V920) from Merck & Co. Inc. (NYSE:MRK) on the heels of last week’s declaration by the World Health Organization of an Ebola virus outbreak in the region.

WHO said on Monday that from April 4 through Sunday there have been two confirmed cases of Ebola and 23 probable and 14 suspected cases. ...